Search
Collaborations * INSIGHT * Publications * Publications 2010
Publications 2010
1 Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients Achhra A, Amin J, Law MG, Emery S, Gerstoft J, Gordin FM, Vjecha MJ, Neaton JD, Cooper DA for INSIGHT ESPRIT & SILCAAT study groups.

AIDS 2010; 24(12):1877-1886. article

2 Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection Baker JV, Neuhaus J, Duprez D, Kuller LH, Tracy R, Belloso WH, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Nixon DE, Paton NI, Neaton JD for the INSIGHT SMART study group.
J Acquir Immun Defic Synd 2010; article

3 Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption Dore GJ, Soriano V, Rockstroh J, Kupfer B, Tedaldi E, Peters L, Neuhaus J, Puoti M, Klein MB, Mocroft A, Clotet B, Lundgren JD for the SMART INSIGHT study group.
AIDS 2010; 24:857-865. 

4 Changes in lipids and lipoprotein particle concentrations after interruption of antiretroviral therapy Lampe FC, Duprez DA, Kuller LH, Tracy R, Otvos J, Stroes E, Cooper DA, Hoy J, Paton NI, Friis-Moller N, Neuhaus J, Liappis AP, Phillips AN for the INSIGHT SMART Study Group.
J Acquir Immun Defic Synd 2010; 54(3):275-284.

5 Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial. Lifson AR, Neuhaus J, Arribas JR, van den Berg-Wolf M, Labriola AM, Read TRH for the INSIGHT SMART Study Group. 

Am J Pub Health 2010; 100(10):1896-1903.article

6 The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parameters Martinez E, Visnegarwala F, Grund B, Thomas A, Gibert C, Shlay J, Drummond F, Pearce D, Edwards S, Reiss P, El-Sadr W, Carr A for the INSIGHT SMART study group. AIDS 2010; 24:353-363.article

7 Regulatory impediments jeopardizing the conduct of clinical trials in Europe funded by the National Institutes of Health Neaton JD, Babiker A, Bohnhorst M, Darbyshire J, Denning E, Frishman A, Grarup J, Larson G and Lundgren J.

Clin Trials 2010; 20 Aug 2010, epub ahead of print .article

8 Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV Neuhaus J, Angus B, Kowalska JD, La Rosa A, Sampson J, Wentworth D, Mocroft A for the INSIGHT SMART and ESPRIT study groups. .

AIDS 2010; 24:697-706.article

9 Markers of inflammation, coagulation and renal function are elevated in adults with HIV infection Neuhaus J, Jacobs Jr. DR, Baker JV, Calmy A, Duprez D, La Rosa A, Kuller LH, Pett SL, Ristola M, Ross MJ, Shlipak MG, Tracy R, Neaton JD for the INSIGHT SMART, MESA and CARDIA Research Groups. .

J Infect Dis 2010; 201(12):1788-1795.article


See also Inflammation and complications of HIV disease

Dube MP, Sattler FR.. (editorial) J Infect Dis 2010; 201(12):1783-1785.article

10 Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT) Pett SL, Carey C, Lin E, Wentworth D, Lazovski J, Miro JM, Gordin F, Angus B, Rodriguez-Barradas M, Rubio R, Tambussi G, Cooper DA, Emery S for the INSIGHT ESPRIT Study Group.

HIV Med 2010; 31 August, epub ahead of print.article

11 Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART study Tavel JA, INSIGHT STALWART Study Group. .

PLoS One 2010; 5(2): e9334. doi:10.1371/journal.pone.0009334. article

12 Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. Wright EJ, Grund B, Robertson K, Brew BJ, Roediger M, Bain MP, Drummond F, Vjecha MJ, Hoy J, Miller C, Penalva de Oliveira AC, Pumpradit W, Shlay JC, El-Sadr W, Price RW for the INSIGHT SMART Study Group. 

Neurology 2010; Aug 11. article


Godsexliv.com